Literature DB >> 17971659

Proinsulin is an independent predictor of the angiographical characteristics of coronary atherosclerosis.

En-Zhi Jia1, Zhi-Jian Yang, Tie-Bing Zhu, Lian-Sheng Wang, Bo Chen, Ke-Jiang Cao, Jun Huang, Wen-Zhu Ma.   

Abstract

OBJECTIVE: The objective of this survey was to study the association between circulating proinsulin level and the severity of coronary atherosclerosis.
METHODS: The study population consisted of 1,039 consecutive patients (775 males and 264 females) who underwent coronary angiography for suspected or known coronary atherosclerosis. The patients' anthropometric and plasma measurements including body mass index, blood pressure, blood lipid, blood glucose, and proinsulin level were performed. The severity of coronary atherosclerosis was defined by the Gensini's score system.
RESULTS: When proinsulin level was examined as a categorical variable classified by quartile values, subjects with a high proinsulin level had significantly higher values of Gensini's score than those with a low proinsulin level (p = 0.000). The Spearman correlation analysis suggests that the Gensini's score was significantly correlated with proinsulin level (r = -0.177, p = 0.000). Multiple stepwise linear regression analysis demonstrated that glucose (beta= 0.136, p = 0.000), age (beta= 0.189, p = 0.000), proinsulin (beta= 0.135, p=0.000), SBP (mm Hg) (beta= -0.061, p = 0.043), fasting low-density lipoprotein cholesterol (mmol/l) (beta= 0.141, p = 0.003), and total cholesterol (beta= -0.105, p = 0.029) are significantly independently associated with the Gensini's score.
CONCLUSIONS: Proinsulin is a strong and statistically highly significant pre- dictor of coronary atherosclerosis independent of the other major risk factors including age, body mass index, blood pressure, fasting blood glucose, and blood lipid. The exact mechanisms need further study. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971659     DOI: 10.1159/000110488

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  3 in total

1.  In type 2 diabetes patients, insulin glargine is associated with lower postprandial release of intact proinsulin compared with sulfonylurea treatment.

Authors:  Stefan Pscherer; Martin Larbig; Berndt von Stritsky; Andreas Pfützner; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

2.  Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial beta-cell protection in individuals with type 2 diabetes.

Authors:  T Forst; M Larbig; C Hohberg; S Forst; S Diessel; M Borchert; W Roth; A Pfützner
Journal:  Diabetes Obes Metab       Date:  2010-05       Impact factor: 6.577

Review 3.  Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.

Authors:  Thomas Forst; Matthias M Weber; Andreas Pfützner
Journal:  Exp Diabetes Res       Date:  2012-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.